Dr. Daniel I. Fremed, MD

Dr. Fremed practices at Overlook Medical Center in Summit, New Jersey, part of Atlantic Health System.

Dr. Fremed's NPI, 1548536436, was assigned on March 26, 2012. Dr. Fremed graduated from Rutgers Robert Wood Johnson Medical School in 2012. Dr. Fremed holds New Jersey license 25MA10034100.

Dr. Fremed's primary practice is Overlook Medical Center, at 99 Beauvoir Avenue, Summit, NJ 07901 in Union County. The practice phone is (908) 522-2000.

Dr. Fremed's primary practice is Overlook Medical Center in Summit, New Jersey, part of Atlantic Health System. Dr. Fremed is also affiliated with Morristown Medical Center. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Fremed to 1 more hospital, 3 medical groups, 2 group practices and clinics and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fremed practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Fremed's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Fremed is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Fremed's licenses on file in 2 states: New Jersey and New York.

Dmand AI lists amputation, arterial blot clot /embolism, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), leg revascularization and lymphedema among the conditions Dr. Fremed treats.

CMS data shows 1,257 Medicare services from Dr. Fremed across 24 procedure codes in 2024, for 781 Medicare patients. Medicare paid $103,282 for them.

CMS counts 781 Medicare patients who saw Dr. Fremed in 2024. The largest group is 75 to 84, with 281 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fremed's median patient age at 72, with 54% women.

In 2024, Dr. Fremed wrote 98 Medicare Part D claims for 44 patients. 68% of them were for generic drugs. CMS names the drug for 72 of them, across 3 drugs with 11 or more claims each, at $31,542 in total drug cost. In 2023, CMS named 98 claims across 4 drugs.

Dr. Fremed accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 32 procedures of leg revascularization (restoring blood flow) by Dr. Fremed, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 14 papers to Dr. Fremed, published from 2013 to 2017. 2016 was the busiest year, with 4. Dr. Fremed has published most often in J Vasc Surg Cases Innov Tech. Dr. Fremed's most frequent co-authors are Peter L. Faries, MD, Michael L. Marin, MD and Daniel Kyung Han, MD.

CMS Open Payments shows 397 general payments to Dr. Fremed from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 72% of the total. W. L. Gore & Associates, Inc. paid the most, $8,556.

Dmand AI lists 2 awards for Dr. Fremed, most recently Phi Beta Kappa in 2008.

Dr. Fremed graduated from Rutgers Robert Wood Johnson Medical School in 2012.

Dr. Fremed is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.